Publications
Here you will find a collection of publications. Some were created with patients in mind and other with health providers in mind.
-
The first of its kind, the Med Ed booklet and its mobile passport version provide educational content and various communication and treatment monitoring tools for people taking medications for mental health problems.
-
This comprehensive review of adverse effects of first- and second-generation antipsychotics provides background information and practical guidance for the detection and monitoring of antipsychotic adverse effects for the clinician.
-
This study surveyed experts with experience in clinical research and use of antipsychotic across the globe in order to develop an internationally representative report of dosing recommendations and clinical equivalencies. It sets the new standard in antipsychotic dosing.
-
This brief article reviews the evidence and argues for the use of folic acid as an add on to standard antidepressants in women with depression.
-
A 71 page report for the Ontario Ministry of Child & Youth Services provides a comprehensive evaluation of Med Ed and its Ontario-based training program. Provided is the evaluation report of Med Ed prepared by the Ontario Centre of Excellence for Child and Youth Mental Health for the Ministry of Child & Youth Services of Ontario. The report provides detailed evaluative information on Med Ed and the related training program used across Ontario.
-
This article outlines the approach taken to design youth oriented and informed resources to support psychopharmacotherapeutic decision-making, as well as the resulting product (Med Ed) and the lessons learned from the process.
-
This article provides a critical review of the second-generation (atypical) antipsychotics in terms of pharmacology, therapeutic effectiveness, tolerability, adverse effects, and costs.
-
This study surveyed experts with experience in clinical research and use of antipsychotic across the globe in order to develop an internationally representative report of dosing recommendations and clinical equivalencies. It sets the new standard in antipsychotic dosing.